Literature DB >> 7629388

Prognostic factors in the management of thyroid cancer.

J Robbins1.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 7629388     DOI: 10.1007/BF03349731

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  7 in total

Review 1.  Genetic basis of endocrine disease 3: Molecular defects in thyroid gland neoplasia.

Authors:  J A Fagin
Journal:  J Clin Endocrinol Metab       Date:  1992-12       Impact factor: 5.958

2.  Papillary thyroid carcinoma.

Authors:  I D Hay
Journal:  Endocrinol Metab Clin North Am       Date:  1990-09       Impact factor: 4.741

Review 3.  Thyroid cancer: a lethal endocrine neoplasm.

Authors:  J Robbins; M J Merino; J D Boice; E Ron; K B Ain; H R Alexander; J A Norton; J Reynolds
Journal:  Ann Intern Med       Date:  1991-07-15       Impact factor: 25.391

4.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.

Authors:  D P Byar; S B Green; P Dor; E D Williams; J Colon; H A van Gilse; M Mayer; R J Sylvester; M van Glabbeke
Journal:  Eur J Cancer       Date:  1979-08       Impact factor: 9.162

5.  An expanded view of risk-group definition in differentiated thyroid carcinoma.

Authors:  B Cady; R Rossi
Journal:  Surgery       Date:  1988-12       Impact factor: 3.982

6.  Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome.

Authors:  M D Brennan; E J Bergstralh; J A van Heerden; W M McConahey
Journal:  Mayo Clin Proc       Date:  1991-01       Impact factor: 7.616

Review 7.  Molecular basis of epithelial tumorigenesis: the thyroid model.

Authors:  D Wynford-Thomas
Journal:  Crit Rev Oncog       Date:  1993
  7 in total
  1 in total

1.  Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.

Authors:  N Lima; H Cavaliere; E Tomimori; M Knobel; G Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.